Advertisement
Screener

COMPLETE GENOMICS INC Financing Cash Flow

COMPLETE GENOMICS INC Financing Cash Flow

COMPLETE GENOMICS INC reported Financing Cash Flow of $3.84 million for the 9-month period ending 2012-09-30, per its 10-Q filed 2012-11-09.

Discontinued › Cash Flow › Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2012-11-09

  • COMPLETE GENOMICS INC net cash provided by (used in) financing activities for the quarter ending 2012-09-30 was $4.01M.
  • COMPLETE GENOMICS INC net cash provided by (used in) financing activities for the quarter ending 2012-06-30 was -$373.00K, a 100.50% decline year-over-year.
  • COMPLETE GENOMICS INC net cash provided by (used in) financing activities for the quarter ending 2012-03-31 was $203.00K, a 98.29% decline year-over-year.
  • COMPLETE GENOMICS INC net cash provided by (used in) financing activities for the quarter ending 2011-12-31 was $427.00K, a 99.38% decline year-over-year.
  • COMPLETE GENOMICS INC net cash provided by (used in) financing activities for fiscal 2011 was $85.81M, a 25.36% decline from fiscal 2010.
  • COMPLETE GENOMICS INC net cash provided by (used in) financing activities for fiscal 2010 was $114.97M, a 203.40% increase from fiscal 2009.
  • COMPLETE GENOMICS INC net cash provided by (used in) financing activities for fiscal 2009 was $37.90M.
Period endNet Cash Provided by (Used in) Financing Activities 3 monthNet Cash Provided by (Used in) Financing Activities 6 monthNet Cash Provided by (Used in) Financing Activities 9 monthNet Cash Provided by (Used in) Financing Activities 12 month
2012-09-30$4.01M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09
$3.64M
derived: sum of 2 quarters · filed 2012-11-09
$3.84M
10-Q · filed 2012-11-09
$4.27M
derived: sum of 4 quarters · filed 2012-11-09
2012-06-30-$373.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09
-$170.00K
10-Q · filed 2012-08-09
$257.00K
derived: sum of 3 quarters · filed 2012-08-09
-$128.00K
derived: sum of 4 quarters · filed 2012-11-09
2012-03-31$203.00K
10-Q · filed 2012-05-09
$630.00K
derived: sum of 2 quarters · filed 2012-05-09
$245.00K
derived: sum of 3 quarters · filed 2012-11-09
$74.12M
derived: sum of 4 quarters · filed 2012-11-09
2011-12-31$427.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-09
$42.00K
derived: sum of 2 quarters · filed 2012-11-09
$73.92M
derived: sum of 3 quarters · filed 2012-11-09
$85.81M
10-K · filed 2012-03-09
2011-09-30-$385.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09
$73.49M
derived: sum of 2 quarters · filed 2012-11-09
$85.39M
10-Q · filed 2012-11-09
$154.25M
derived: sum of 4 quarters · filed 2012-11-09
2011-06-30$73.88M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09
$85.77M
10-Q · filed 2012-08-09
$154.63M
derived: sum of 3 quarters · filed 2012-08-09
$170.66M
derived: sum of 4 quarters · filed 2012-08-09
2011-03-31$11.89M
10-Q · filed 2012-05-09
$80.76M
derived: sum of 2 quarters · filed 2012-05-09
$96.79M
derived: sum of 3 quarters · filed 2012-05-09
2010-12-31$68.86M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-09
$84.89M
derived: sum of 2 quarters · filed 2012-03-09
$114.97M
10-K · filed 2012-03-09
2010-09-30$16.03M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14
$46.11M
10-Q · filed 2011-11-14
2010-06-30$30.08M
10-Q · filed 2011-08-15
2009-12-31$37.90M
10-K · filed 2012-03-09